Clinical Trials in Phoenix

Showing 7261-7280 of 16,646 trials

Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures

NCT04970212

Clinical study planned to demonstrate that the BioTraceIO Lite, available post-procedure, is effective at estimating the area of tissue damage as measured on 24-hour post-procedure (T=24hrs) CECT scan and that it is safe, based on an assessment of device-related Adverse Events. Multi-center (up to 6 investigational sites) prospective single-arm clinical investigation 50 evaluable subjects total stratified by cancer type (primary hepatocellular carcinoma vs. secondary liver metastases).

Carcinoma, HepatocellularMetastatic Liver Cancer

Techsomed Medical Technologies LTD65 participantsStarted Sep 2021

Phoenix, Arizona, United States • Stanford, California, United States • Boston, Massachusetts, United States +3 more locations

UNKNOWNNA< 1 mile

The SUN Clinical Trial (Safety Utilizing NUsurface Meniscus Implant)

NCT02483988

The NUsurface® Meniscus Implant SUN Clinical Trial is a multi-center, single-arm, prospective, open label, non-randomized, observational clinical trial to gather safety and probable clinical benefit data on the NUsurface® Meniscus Implant in treated the target population.

Post-Meniscectomy Pain SyndromeOsteoarthritis, Knee

Active Implants115 participantsStarted Dec 2015

Phoenix, Arizona, United States • La Mesa, California, United States • Long Beach, California, United States +10 more locations

Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures

The SUN Clinical Trial (Safety Utilizing NUsurface Meniscus Implant)

Find Trials by Condition in Phoenix

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)

ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi

Intraoperative Brachytherapy for Central Nervous System Lesions: A Validation Study of a Radioactive Seed Loading Device

VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis

Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)

A Study to Assess the Pharmacokinetic (PK) Comparability of 2 Fixed Subcutaneous (SC) Doses of Aducanumab (BIIB037) With a Single, Weight-Based Intravenous (IV) Dose in Healthy Volunteers

A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers

Thrombosomes® in Bleeding Thrombocytopenic Patients

A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants

A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)

Acquired Methemoglobinemia Observational Registry

Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Remodeling

Improving Cognition Via Exercise in Schizophrenia

Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)

Point-of-Care Immunoassay for Detection of Bacterial Sinusitis

Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002)